Solazyme Inc. (SZYM) Jumps 6.43% on February 15

Equities Staff |

Solazyme Inc. (SZYM) was among the biggest gainers on the Russell 2000 for Monday February 15 as the stock popped 6.43% to $1.49, representing a gain of $0.09 per share. Some 278,117 shares traded hands on 992 trades, compared with an average daily volume of 507,707 shares out of a total float of 80.54 million. The stock opened at $1.41 and traded with an intraday range of $1.49 to $1.39.

After today's gains, Solazyme Inc. reached a market cap of $120 million. Solazyme Inc. has had a trading range between $4.74 and $1.18 over the last year, and it had a 50-day SMA of $2.11 and a 200-day SMA of $2.75.

Solazyme Inc, along with its subsidiaries, is engaged in providing renewable oils and other bioproducts. It commercializes its products into target markets such as chemicals and fuels, nutrition, and skin and personal care.

Solazyme Inc. is based out of South San Francisco, CA and has some 266 employees. Its CEO is Jonathan S. Wolfson.

For a complete fundamental analysis analysis of Solazyme Inc., check out Equities.com’s Stock Valuation Analysis report for SZYM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…